Litigation (Narrative) (Details) £ in Thousands, case in Thousands, € in Millions, $ in Millions								1 Months Ended		3 Months Ended	12 Months Ended
	Jun. 17, 2019 patent agreement	Jun. 17, 2019 patent	Sep. 10, 2018 patent	Oct. 24, 2017 patent	Jun. 30, 2017 patent	Feb. 12, 2016 GBP (£)	Jul. 09, 2014 EUR (€)	Feb. 28, 2022 USD ($)	Jun. 19, 2013 EUR (€)	Dec. 31, 2014 USD ($)	Dec. 31, 2021 USD ($) state agreement case increase	Dec. 31, 2021 GBP (£) state case	Apr. 02, 2020 patent
Loss Contingencies [Line Items]
Number of cases | case											1	1
Product Liability
Loss Contingencies [Line Items]
Loss contingency accrual											$ 74.8
Intellectual Property
Loss Contingencies [Line Items]
Loss contingency accrual											$ 226.9
Number of times damages may be increased in cases of willful infringement | increase											3
Other Foreign Operations
Loss Contingencies [Line Items]
Loss contingency accrual											$ 8.4
MDL
Loss Contingencies [Line Items]
Number of states | state											47	47
Anticompetitive Conduct with Doxycycline Hyclate Delayed Release, Doxycycline Monohydrate, Glipizide-Metformin and Verapamil
Loss Contingencies [Line Items]
Number of states | state											37	37
Anticompetitive Conduct with Generic Drugs
Loss Contingencies [Line Items]
Number of states | state											48	48
Amended Anticompetitive Conduct with Generic Drugs
Loss Contingencies [Line Items]
Number of states | state											43	43
EU Commission Proceedings Perindorpril | Antitrust Proceedings | Mylan Laboratories Limited
Loss Contingencies [Line Items]
Damages awarded | €							€ 17.2
Loss contingency accrual										$ 21.7
U.K. Competition and Markets Authority Proceedings Paroxetine
Loss Contingencies [Line Items]
Damages awarded | £						£ 5,800
Loss Contingency, Damages Awarded On Appeal, Value | £						3,900
U.K. Competition and Markets Authority Proceedings Paroxetine | Mylan
Loss Contingencies [Line Items]
Loss contingency accrual | £												£ 8,800
Damages awarded | £						2,700
Loss Contingency, Damages Awarded On Appeal, Value | £						£ 2,050
EU Commission Proceedings Citalopram
Loss Contingencies [Line Items]
Loss contingency accrual											$ 11.4
Damages awarded | €									€ 7.8
Dimethyl Fumarate
Loss Contingencies [Line Items]
Loss Contingency, Patents Allegedly Infringed, Number | patent					6
Insulin Glargine
Loss Contingencies [Line Items]
Loss Contingency, Patents Allegedly Infringed, Number | patent			5	18
Loss Contingency, Patents Found Not Infringed, Number	12	3
Loss Contingency, Remaining Claims, Number | patent	4	4		2									2
Loss Contingency, Other Asserted Patents, Number | patent	16	16
EpiPen Auto-Injector Litigation
Loss Contingencies [Line Items]
Loss contingency accrual											$ 264.0
Loss Contingency, Number of States | agreement											17
EpiPen Auto-Injector Litigation | Subsequent Event
Loss Contingencies [Line Items]
Amount awarded to other party								$ 264.0
EpiPen Auto-Injector Litigation | Other current liabilities
Loss Contingencies [Line Items]
Estimated Litigation Liability											$ 274.0